NASDAQ:ARTV

Artiva Biotherapeutics . Common Stock Stock Forecast

etoro logo Buy ARTV
*Your capital is at risk
$11.59
+0.520 (+4.70%)
At Close: Aug 05, 2026

Should you buy ARTV stock?

Last updated:

Based on market data through , StockInvest.us rates Artiva Biotherapeutics, Inc. Common Stock (ARTV) as a Strong Buy Candidate with a technical score of 7.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 24.49%
  • 3-month trend forecast Up 9.37%
  • Strong Buy Candidate 7.42
AI Analysis AI Analysis of ARTV AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ARTV to Watchlist?
Some Reasons Why To Add ARTV:
  • +303.8% price growth over the last year
  • +174.0% YTD performance
  • Bullish trend confirmed on both short and long timeframes
PDF

High volatility in Artiva Biotherapeutics, Inc. Common stock price on Wednesday which ended trading at $11.59
(Market data through Aug 05, 2026)

Buy or Hold candidate since Jul 08, 2026 Gain 24.49%

The Artiva Biotherapeutics, Inc. Common stock price gained 4.70% on the last trading day (Wednesday, 5th Aug 2026), rising from $11.07 to $11.59. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.29% from a day low at $10.65 to a day high of $11.74. The price has risen in 7 of the last 10 days and is up by 15.67% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 154 thousand more shares were traded than the day before. In total, 548 thousand shares were bought and sold for approximately $6.36 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.37% during the next 3 months and, with a 90% probability hold a price between $8.26 and $14.95 at the end of this 3-month period.

ARTV Signals & Forecast

Mostly positive signals in the chart today. The Artiva Biotherapeutics, Inc. Common stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.64 and $9.79. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 70.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Artiva Biotherapeutics, Inc. Common stock

On the downside, the stock finds support just below today's level from accumulated volume at $10.89 and $9.82. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Artiva Biotherapeutics, Inc. Common finds support just below today's level at $10.89. If this is broken, then the next support from accumulated volume will be at $9.82 and $9.62.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.10 between high and low, or 10.29%. For the last week, the stock has had daily average volatility of 8.21%.

Our recommended stop-loss: $11.18 (-3.54%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 40 days ago.)

Trading Expectations (ARTV) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Artiva Biotherapeutics, Inc. Common Stock to open at $11.33, and during the day (based on 14 day Average True Range), to move between $11.15 and $12.03, which gives a possible trading interval of +/-$0.87 (+/-7.81%) up or down from last closing price. If Artiva Biotherapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 7.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.89 (6.04%) than the resistance at $12.39 (6.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Artiva Biotherapeutics, Inc. Common Stock stock A Buy?

Artiva Biotherapeutics, Inc. Common holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 7.423 Strong Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $11.33 ( 2.29%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ARTV Performance

Trading levels for ARTV

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 12.42 7.16%
R2 12.00 3.55%
R1 11.74 1.32%
Price 11.59
S1 10.91 -5.90%
S2 10.65 -8.13%
S3 10.23 -11.73%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 12.52 8.02%
R1 12.39 6.90%
Price 11.59
S1 10.89 -6.04%
S2 9.82 -15.27%
S3 9.62 -17.00%

FAQ

What is the symbol for Artiva Biotherapeutics, Inc. Common Stock Stock and on which exchange is it traded?
The symbol for Artiva Biotherapeutics, Inc. Common Stock is ARTV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Artiva Biotherapeutics, Inc. Common Stock Stock?
Based on market data through Aug 05, 2026, StockInvest.us rates Artiva Biotherapeutics, Inc. Common Stock (ARTV) as a Strong Buy Candidate with a technical score of 7.42 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jul 08, 2026, the price has risen 24.49%. The current 3-month trend forecast projects a rise of 9.37%.

How to buy Artiva Biotherapeutics, Inc. Common Stock Stock?
Artiva Biotherapeutics, Inc. Common Stock Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Artiva Biotherapeutics, Inc. Common Stock Stock.

What's the current price of Artiva Biotherapeutics, Inc. Common Stock Stock?
As of the end of day on the Aug 05, 2026, the price of an Artiva Biotherapeutics, Inc. Common Stock (ARTV) share was $11.59.

What is the 52-week high and low for Artiva Biotherapeutics, Inc. Common Stock Stock?
The 52-week high for Artiva Biotherapeutics, Inc. Common Stock Stock is $14.53 and the 52-week low is $2.24.

What is the market capitalization of Artiva Biotherapeutics, Inc. Common Stock Stock?
As of the Aug 05, 2026, the market capitalization of Artiva Biotherapeutics, Inc. Common Stock is 286.472M.

When is the next earnings date for Artiva Biotherapeutics, Inc. Common Stock?
The upcoming earnings date for Artiva Biotherapeutics, Inc. Common Stock is Aug 05, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE